Abstract
Mixed phenotype acute leukemia symbolizes a very small subset of acute leukemia that simply cannot be allocated as lymphoid or myeloid lineage. The 2008 World Health Organisation classification established stringent standard for diagnosis of mixed phenotype acute leukemia, accentuating myeloperoxidase for myeloid lineage, cytoplasmic CD3 for T lineage and CD19 with other B markers for B lineage obligation. Mixed phenotype leukemia is rare and 3–5 % of acute leukmias of all age groups, is associated with poor outcome with overall survival of 18 months. We wish to present two cases of mixed phenotypic acute leukemia who presented with mediastinal masses, were suspected to be T cell lymphoma/leukemia clinically and radiologically. In one case, tissue diagnosis was given as lymphoma for which treatment was given. These cases show that patients diagnosed as lymphoma on histopathology can be cases of mixed phenotype acute leukemia and varying specific treatment protocols and follow up are required. Awareness of these entities will help in proper diagnosis and treatment.
References
Borowitz MJ, Chan JKC (2008) T lymphoblastic leukemia/lymphoma. In: Swerdlow SH, Campo E, Harris NL et al (eds) World Health Organisation classification of tumours: pathology and genetics of tumours of hematopoietic and lymphoid tissues. IARC Press, Lyon, pp 176–178
Manjusha N, Kusumakumary P, Sindhu NP (2014) Acute myeloid leukemia presenting as mediastinal mass. Indian J Paediatr 81(8):824–825
Chen G, Sands AM, Jianlan S (2012) Mixed phenotype acute leukemias. N A J Med Sci. 5(2):119–122
Rubnitz JE, Onciu M, Pounds S et al (2009) Acute mixed lineage leukemia in children: the experience of St. Jude Children’s Research Hospital. Blood 113(21):5083–5089
Matutes E, Pickl WF, van’t Veer M et al (2011) Mixed phenotype acute leukemia (MPAL): clinical and laboratory features and outcome in 100 patients defined according to WHO 2008 classification. Blood 117(11):3163–3171
Borowitz M, Been MC, Harris NL, Profit A, Matutes E (2008) Acute leukemias of ambiguous lineage. In: Swerdlo SH, Campo E, Harris NL et al (eds) World Health Organisation classification of tumours: pathology and genetics of tumours of hematopoietic and lymphoid tissues. IARC Press, Lyon, pp 150–155
Bene MC, Castoldi G, Knapp W et al (1995) Proposals for the immunological classification of acute leukemias. European Group for Immunological Characterization of Leukemias (EGIL). Leukemia 9(10):1783–1786
Kawamoto H (2006) A close developmental relationship between the lymphoid and myeloid lineages. Trends Immunol 27(4):169–175
Zheng CC, Wu JS, Liu X et al (2009) What is the optimal treatment for biphenotypic acute leukemia? Haematologica 94(12):1778–1780
Legrand O, Perrot JY, Simonin G et al (1998) Adult biphenotypic acute leukemias: an entity with poor prognosis which is related to unfavourable cytogenetics and p-glycoprotein over-expression. Br J Haematol 100(1):147–155
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have none to declare.
Rights and permissions
About this article
Cite this article
Vardhan, R., Kotwal, J., Ganguli, P. et al. Mixed Phenotypic Acute Leukemia Presenting as Mediastinal Mass-2 Cases. Indian J Hematol Blood Transfus 32 (Suppl 1), 72–77 (2016). https://doi.org/10.1007/s12288-015-0611-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-015-0611-5